Skip to content

Find our latest news, stories and press releases

Delivering long-term value for our stakeholders

Explore career opportunities and more

Impacting health for humanity

  1. Home/
  2. News/
  3. Health & wellness/
  4. Freedom of breath, fountain of life: How a first-of-its-kind partnership has saved thousands of babies in China

Freedom of breath, fountain of life: How a first-of-its-kind partnership has saved thousands of babies in China

Helping Babies Breathe

A quadruplet baby from the Shen family who needed neonatal resuscitation at birth

Childbirth should be a moment to celebrate the miracle of life, but as many as 1 in 10 newborns are unable to breathe upon entering the world.

The condition, known as birth asphyxia, is among the world’s leading causes of infant death. And a decade ago, it accounted for 20% of China’s infant mortality rate—that’s a shocking 73,000 babies lost each year.

But a simple, low-tech medical technique called neonatal resuscitation can help prevent it. That’s why Johnson & Johnson partnered with the Chinese Ministry of Health and other organizations in an effort to ensure that caregivers in every Chinese hospital received the training they needed to administer the procedure.

Ten years later, we’re proud to say that this unique public/private partnership, known as “Freedom of Breath, Fountain of Life,” has helped over 100,000 Chinese babies take their first breath. And after a decade of success, we’re committed to keeping the partnership going for another five years.

But don’t just take our word for it: Watch the moving video below and meet six kids who are alive and thriving, thanks to the historic partnership that empowered everyone from midwives to doctors to save precious lives.

More from Johnson & Johnson

Moving toward a more personalized approach to treating depression

The World Health Organization predicts that depression will be the leading cause of disability across the globe by 2030. Learn how Johnson & Johnson is on a mission to change that.

“Our goal is a solution for every bladder cancer patient”

Meet Christopher Cutie, M.D., the Johnson & Johnson scientist who’s helping change the treatment landscape for people with bladder cancer, the tenth most common cancer in the world.

Is this the end of one-size-fits-all treatments for depression?

Learn how Johnson & Johnson is working to better address the needs of the 7 in 10 people with depression whose treatments aren’t providing enough relief.